We treated seven patients with discoid lupus erythematosus (DLE) with Vitamin E in an oral dose of 400 mg three times per day for 12 weeks. All other systemic and topical treatments were discontinued 1 month before initiation of the trial. The drug was then stopped and follow-up continued for at least another 4 weeks. No patient showed clearing of lesions. The trial was conducted during summer, when DLE is likely to be most active. There was no deterioration in any patient. No side effects were noted.
Ayres S. Jr, Mihan R.Vitamin E as a useful therapeutic agent. J Am Acad Dermatol1983; 8: 133-4.
2.
Finnen MJ, Lawrence CM, Shuster S.Inhibition of dithranol inflammation by free radical scavengers. Lancet1984; ii: 1129-30.
3.
Ayres S.Vitamin E: an effective therapeutic agent in dermatology. In: Epstein E, ed. Controversies in Dermatology . London: WB Saunders Company, 1984: 379-85.
4.
Ayres S. Jr, Mihan R.Lupus erythematosus and Vitamin E: an effective and nontoxic therapy . Cutis1979; 23: 49.
5.
Truswell ASVitamins II (ABC of Nutrition). London: British Medical Association, 1986: 62.
6.
Williams HC, Buffham R., du VivierA. Successful use of topical Vitamin E solution in the treatment of nail changes in yellow nail syndrome. Arch Dermatol1991 ; 127: 1023-8.
7.
Goldsmith S.Vitamin E and onychomycosis. J Am Acad Dermatol1983; 8: 910-1.
8.
Stout OMPseudoxanthoma elasticum with retinal angioid streaking decidedly improving on tocopherol therapy. Arch Dermatol1351; 63: 510.
9.
Ayres S. Jr, Mihan R., Levan NE, Rapaport J., Couperus M.Raynaud's phenomenon, scleroderina, morphea and calcinosis cutis: response to Vitamin ECutis1973; 11: 54.
10.
Biere JG, Corash L., Hubbard VSMedical uses of Vitamin E. N Engl J Med1983 ; 308: 1063-71.
11.
Lockshin MDTherapy for systemic lupus erythematosus. N Engl J Med1991; 324: 189-91.
12.
Austin HA, Klippel JH, Balow JE et al. Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs. N Engl J Med1986; 314: 614-9.
